<--- Back to Details
First PageDocument Content
Center for Biologics Evaluation and Research / Investigational New Drug / New Drug Application / Federal Food /  Drug /  and Cosmetic Act / Biologic License Application / Medical device / Title 21 CFR Part 11 / Food and Drug Administration / Medicine / Health
Center for Biologics Evaluation and Research
Investigational New Drug
New Drug Application
Federal Food
Drug
and Cosmetic Act
Biologic License Application
Medical device
Title 21 CFR Part 11
Food and Drug Administration
Medicine
Health

Microsoft Word - 9255dft_[removed]doc

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 175,81 KB

Share Document on Facebook

Similar Documents

TOWARDS A SOCIOLOGY OF HARM REDUCTION: A COMPARATIVE STUDY OF DRUG POLICY CHANGE IN CANADA AND THE UNITED KINGDOM BETWEEN THE YEARS 1985 AND 2017 by

TOWARDS A SOCIOLOGY OF HARM REDUCTION: A COMPARATIVE STUDY OF DRUG POLICY CHANGE IN CANADA AND THE UNITED KINGDOM BETWEEN THE YEARS 1985 AND 2017 by

DocID: 1xVT2 - View Document

Federal Register / Vol. 83, NoFriday, March 16, Proposed Rules Food and Drug Administration 21 CFR Part 1130

Federal Register / Vol. 83, NoFriday, March 16, Proposed Rules Food and Drug Administration 21 CFR Part 1130

DocID: 1xVJS - View Document

What is a Vulnerability Disclosure Policy and Why You Need One VDPs work and they protect assets. That’s why the U.S. Department of Justice, the European Commission, and the U.S. Food & Drug Administration recommend th

What is a Vulnerability Disclosure Policy and Why You Need One VDPs work and they protect assets. That’s why the U.S. Department of Justice, the European Commission, and the U.S. Food & Drug Administration recommend th

DocID: 1xVfx - View Document

Notice to Industry: Additional Tobacco Products Now Regulated by the Food and Drug Administration

Notice to Industry: Additional Tobacco Products Now Regulated by the Food and Drug Administration

DocID: 1xVey - View Document

August 7, 2018 Dr. Scott Gottlieb Commissioner, Food and Drug AdministrationNew Hampshire Avenue Silver Spring, MarylandDear Dr. Gottlieb:

August 7, 2018 Dr. Scott Gottlieb Commissioner, Food and Drug AdministrationNew Hampshire Avenue Silver Spring, MarylandDear Dr. Gottlieb:

DocID: 1xUNE - View Document